| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Milk, Human | 59 | 2025 | 201 | 13.480 |
Why?
|
| Breast Feeding | 56 | 2025 | 170 | 11.630 |
Why?
|
| Infant, Very Low Birth Weight | 50 | 2022 | 188 | 10.290 |
Why?
|
| Intensive Care Units, Neonatal | 59 | 2025 | 210 | 9.200 |
Why?
|
| Infant, Premature | 60 | 2025 | 218 | 8.510 |
Why?
|
| Mothers | 40 | 2025 | 186 | 7.950 |
Why?
|
| Infant, Newborn | 109 | 2025 | 642 | 6.070 |
Why?
|
| Lactation | 23 | 2023 | 62 | 5.060 |
Why?
|
| Breast Milk Expression | 13 | 2020 | 42 | 4.850 |
Why?
|
| Intensive Care, Neonatal | 11 | 2020 | 37 | 3.100 |
Why?
|
| Infant Nutritional Physiological Phenomena | 28 | 2025 | 80 | 3.090 |
Why?
|
| Infant | 30 | 2025 | 564 | 2.160 |
Why?
|
| Enterocolitis, Necrotizing | 11 | 2020 | 49 | 2.060 |
Why?
|
| Female | 80 | 2025 | 15212 | 1.840 |
Why?
|
| Mother-Child Relations | 7 | 2017 | 28 | 1.760 |
Why?
|
| Humans | 112 | 2025 | 27072 | 1.690 |
Why?
|
| Child Development | 10 | 2020 | 73 | 1.560 |
Why?
|
| Infant, Premature, Diseases | 7 | 2020 | 30 | 1.490 |
Why?
|
| Neonatal Nursing | 12 | 2018 | 19 | 1.460 |
Why?
|
| Gestational Age | 16 | 2020 | 89 | 1.330 |
Why?
|
| Peer Group | 6 | 2017 | 35 | 1.330 |
Why?
|
| Social Support | 6 | 2019 | 196 | 1.200 |
Why?
|
| Maternal Behavior | 4 | 2017 | 11 | 1.200 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2019 | 18 | 1.120 |
Why?
|
| Adult | 38 | 2025 | 7831 | 1.050 |
Why?
|
| Milk Banks | 6 | 2020 | 22 | 1.000 |
Why?
|
| Bottle Feeding | 8 | 2016 | 16 | 0.990 |
Why?
|
| Health Care Costs | 5 | 2020 | 75 | 0.990 |
Why?
|
| Patient Discharge | 9 | 2025 | 158 | 0.990 |
Why?
|
| Prospective Studies | 19 | 2019 | 1778 | 0.960 |
Why?
|
| Counseling | 5 | 2013 | 42 | 0.890 |
Why?
|
| Postpartum Period | 3 | 2021 | 24 | 0.870 |
Why?
|
| Goals | 4 | 2017 | 43 | 0.850 |
Why?
|
| Infant, Low Birth Weight | 7 | 2019 | 18 | 0.820 |
Why?
|
| Male | 38 | 2025 | 14772 | 0.800 |
Why?
|
| Infant, Newborn, Diseases | 4 | 2020 | 15 | 0.790 |
Why?
|
| Precision Medicine | 1 | 2022 | 26 | 0.790 |
Why?
|
| Socioeconomic Factors | 4 | 2020 | 302 | 0.740 |
Why?
|
| Postnatal Care | 2 | 2013 | 7 | 0.720 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 88 | 0.690 |
Why?
|
| Educational Status | 5 | 2019 | 293 | 0.690 |
Why?
|
| Social Determinants of Health | 1 | 2020 | 32 | 0.680 |
Why?
|
| Nutritive Value | 5 | 2020 | 25 | 0.670 |
Why?
|
| Health Promotion | 4 | 2013 | 143 | 0.660 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 25 | 0.650 |
Why?
|
| Enteral Nutrition | 4 | 2018 | 66 | 0.650 |
Why?
|
| Contraception Behavior | 1 | 2019 | 5 | 0.640 |
Why?
|
| Sepsis | 3 | 2019 | 113 | 0.610 |
Why?
|
| Anthropometry | 6 | 2007 | 34 | 0.600 |
Why?
|
| Hospitalization | 6 | 2019 | 300 | 0.570 |
Why?
|
| Birth Weight | 7 | 2020 | 46 | 0.570 |
Why?
|
| Stress, Psychological | 2 | 2019 | 235 | 0.540 |
Why?
|
| Child Language | 2 | 2017 | 19 | 0.540 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2019 | 231 | 0.540 |
Why?
|
| Chicago | 7 | 2017 | 949 | 0.540 |
Why?
|
| Resilience, Psychological | 1 | 2017 | 26 | 0.530 |
Why?
|
| Infant Care | 6 | 2016 | 19 | 0.520 |
Why?
|
| Depression, Postpartum | 2 | 2017 | 14 | 0.520 |
Why?
|
| Puerperal Disorders | 1 | 2015 | 5 | 0.490 |
Why?
|
| Infant Formula | 6 | 2020 | 22 | 0.480 |
Why?
|
| Cost Savings | 1 | 2015 | 32 | 0.470 |
Why?
|
| Longitudinal Studies | 8 | 2019 | 1368 | 0.470 |
Why?
|
| Young Adult | 7 | 2019 | 1994 | 0.470 |
Why?
|
| Retrospective Studies | 12 | 2025 | 3538 | 0.470 |
Why?
|
| Weight Gain | 5 | 2018 | 64 | 0.460 |
Why?
|
| Suction | 3 | 2010 | 40 | 0.450 |
Why?
|
| Energy Intake | 4 | 2018 | 83 | 0.450 |
Why?
|
| Research Support as Topic | 2 | 2005 | 14 | 0.450 |
Why?
|
| Motor Activity | 2 | 2017 | 323 | 0.450 |
Why?
|
| Infant, Extremely Low Birth Weight | 3 | 2012 | 23 | 0.450 |
Why?
|
| Retinopathy of Prematurity | 1 | 2014 | 7 | 0.450 |
Why?
|
| Patient Education as Topic | 5 | 2013 | 131 | 0.440 |
Why?
|
| Intestines | 2 | 2013 | 80 | 0.440 |
Why?
|
| Anxiety Disorders | 1 | 2015 | 171 | 0.440 |
Why?
|
| Hospital Costs | 1 | 2013 | 59 | 0.400 |
Why?
|
| Direct Service Costs | 1 | 2012 | 4 | 0.400 |
Why?
|
| Attitude to Health | 1 | 2013 | 99 | 0.390 |
Why?
|
| Premature Birth | 2 | 2023 | 11 | 0.380 |
Why?
|
| Perception | 2 | 2020 | 77 | 0.380 |
Why?
|
| Breast | 2 | 2008 | 28 | 0.370 |
Why?
|
| Nurse's Role | 5 | 2007 | 59 | 0.370 |
Why?
|
| Risk Factors | 7 | 2016 | 2302 | 0.360 |
Why?
|
| Reproducibility of Results | 10 | 2006 | 676 | 0.350 |
Why?
|
| United States | 10 | 2020 | 2035 | 0.340 |
Why?
|
| Incidence | 6 | 2020 | 759 | 0.340 |
Why?
|
| Nurseries, Hospital | 2 | 2007 | 3 | 0.320 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 261 | 0.320 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2017 | 164 | 0.310 |
Why?
|
| Clinical Nursing Research | 2 | 2002 | 4 | 0.310 |
Why?
|
| Child, Preschool | 3 | 2020 | 641 | 0.310 |
Why?
|
| Cognition | 2 | 2017 | 1339 | 0.300 |
Why?
|
| Diet | 3 | 2018 | 220 | 0.300 |
Why?
|
| Qualitative Research | 4 | 2017 | 114 | 0.300 |
Why?
|
| Lipids | 2 | 2006 | 51 | 0.300 |
Why?
|
| Animals | 7 | 2020 | 3642 | 0.290 |
Why?
|
| Body Weight | 6 | 1996 | 134 | 0.290 |
Why?
|
| Child | 4 | 2021 | 1295 | 0.290 |
Why?
|
| Biomarkers | 3 | 2020 | 562 | 0.290 |
Why?
|
| Anxiety | 2 | 2019 | 156 | 0.280 |
Why?
|
| Maternal Age | 3 | 2019 | 15 | 0.260 |
Why?
|
| Interviews as Topic | 3 | 2017 | 132 | 0.260 |
Why?
|
| Costs and Cost Analysis | 2 | 2019 | 32 | 0.260 |
Why?
|
| Residence Characteristics | 2 | 2019 | 214 | 0.260 |
Why?
|
| Maternal-Child Nursing | 2 | 2004 | 4 | 0.260 |
Why?
|
| Centrifugation | 1 | 2006 | 4 | 0.250 |
Why?
|
| Colostrum | 3 | 2010 | 5 | 0.250 |
Why?
|
| Decision Making | 4 | 2015 | 223 | 0.240 |
Why?
|
| Milk Ejection | 3 | 2011 | 3 | 0.240 |
Why?
|
| Research | 1 | 2005 | 39 | 0.240 |
Why?
|
| Child Nutrition Sciences | 1 | 2005 | 3 | 0.240 |
Why?
|
| Adolescent | 7 | 2017 | 2172 | 0.230 |
Why?
|
| Evidence-Based Practice | 2 | 2016 | 72 | 0.230 |
Why?
|
| Parent-Child Relations | 1 | 2004 | 37 | 0.230 |
Why?
|
| Cohort Studies | 6 | 2020 | 1890 | 0.220 |
Why?
|
| Toxoplasmosis, Congenital | 3 | 2011 | 8 | 0.220 |
Why?
|
| Mass Media | 1 | 2004 | 10 | 0.220 |
Why?
|
| Nursing Evaluation Research | 4 | 2015 | 19 | 0.210 |
Why?
|
| Pregnancy | 7 | 2019 | 336 | 0.210 |
Why?
|
| Financing, Government | 1 | 2003 | 9 | 0.210 |
Why?
|
| Parents | 1 | 2004 | 113 | 0.210 |
Why?
|
| Nutritional Status | 2 | 2020 | 58 | 0.210 |
Why?
|
| Health Policy | 1 | 2003 | 42 | 0.200 |
Why?
|
| Aftercare | 3 | 2018 | 24 | 0.200 |
Why?
|
| Cost of Illness | 2 | 2013 | 50 | 0.200 |
Why?
|
| Nutritional Support | 3 | 2018 | 24 | 0.190 |
Why?
|
| Attitude of Health Personnel | 2 | 2013 | 145 | 0.180 |
Why?
|
| Oxidative Stress | 2 | 2018 | 94 | 0.180 |
Why?
|
| Age Factors | 2 | 2020 | 766 | 0.180 |
Why?
|
| Health Expenditures | 1 | 2020 | 17 | 0.180 |
Why?
|
| Neonatology | 1 | 2020 | 4 | 0.170 |
Why?
|
| Protective Devices | 1 | 2000 | 2 | 0.170 |
Why?
|
| Nipples | 1 | 2000 | 5 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 3 | 2020 | 123 | 0.170 |
Why?
|
| Tissue Donors | 2 | 2021 | 79 | 0.170 |
Why?
|
| Linear Models | 3 | 2017 | 247 | 0.160 |
Why?
|
| Child of Impaired Parents | 1 | 2019 | 10 | 0.160 |
Why?
|
| Intestinal Mucosa | 2 | 2018 | 156 | 0.160 |
Why?
|
| Time Factors | 6 | 2018 | 1433 | 0.160 |
Why?
|
| Directive Counseling | 1 | 2019 | 12 | 0.160 |
Why?
|
| Intention | 1 | 2019 | 21 | 0.160 |
Why?
|
| Acute Disease | 1 | 2019 | 176 | 0.160 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 45 | 0.160 |
Why?
|
| Body Mass Index | 1 | 2021 | 458 | 0.160 |
Why?
|
| Program Evaluation | 2 | 2013 | 120 | 0.160 |
Why?
|
| Inflammation | 2 | 2018 | 272 | 0.160 |
Why?
|
| Obesity | 1 | 2021 | 311 | 0.150 |
Why?
|
| Return to Work | 2 | 2016 | 65 | 0.150 |
Why?
|
| Feeding Methods | 2 | 2013 | 5 | 0.150 |
Why?
|
| Pilot Projects | 2 | 2018 | 420 | 0.150 |
Why?
|
| Social Class | 1 | 2019 | 67 | 0.150 |
Why?
|
| Biomedical Research | 2 | 2016 | 56 | 0.150 |
Why?
|
| Depression | 2 | 2019 | 444 | 0.150 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 329 | 0.150 |
Why?
|
| Cell Death | 1 | 2018 | 45 | 0.150 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 1792 | 0.150 |
Why?
|
| Sucking Behavior | 2 | 1994 | 2 | 0.140 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 77 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 18 | 0.140 |
Why?
|
| Nervous System | 1 | 2017 | 11 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 370 | 0.140 |
Why?
|
| Pregnancy in Adolescence | 1 | 2017 | 11 | 0.140 |
Why?
|
| Eating | 2 | 2011 | 58 | 0.140 |
Why?
|
| Narration | 1 | 2017 | 12 | 0.140 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 68 | 0.130 |
Why?
|
| Tissue and Organ Procurement | 1 | 2016 | 37 | 0.130 |
Why?
|
| Program Development | 2 | 2014 | 51 | 0.130 |
Why?
|
| Science | 1 | 1996 | 4 | 0.130 |
Why?
|
| Nurse-Patient Relations | 2 | 2015 | 44 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 879 | 0.130 |
Why?
|
| Weaning | 1 | 2016 | 5 | 0.130 |
Why?
|
| Nutrition Assessment | 1 | 1996 | 42 | 0.130 |
Why?
|
| Adaptation, Psychological | 1 | 2017 | 175 | 0.130 |
Why?
|
| Illinois | 1 | 2016 | 250 | 0.130 |
Why?
|
| Informed Consent | 1 | 2015 | 23 | 0.120 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 57 | 0.120 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 47 | 0.120 |
Why?
|
| Nigeria | 2 | 2007 | 4 | 0.120 |
Why?
|
| Bacteria | 1 | 2016 | 70 | 0.120 |
Why?
|
| Chondroitinases and Chondroitin Lyases | 1 | 2015 | 4 | 0.120 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2015 | 14 | 0.120 |
Why?
|
| Incubators, Infant | 2 | 1995 | 2 | 0.120 |
Why?
|
| Life Change Events | 1 | 2015 | 37 | 0.120 |
Why?
|
| Length of Stay | 1 | 2017 | 313 | 0.120 |
Why?
|
| Ambulatory Care | 1 | 2015 | 69 | 0.110 |
Why?
|
| Beds | 1 | 1994 | 3 | 0.110 |
Why?
|
| Home Nursing | 1 | 1994 | 33 | 0.110 |
Why?
|
| Nursing Staff, Hospital | 2 | 1993 | 25 | 0.110 |
Why?
|
| Morbidity | 1 | 2014 | 54 | 0.110 |
Why?
|
| Focus Groups | 1 | 1994 | 87 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 482 | 0.110 |
Why?
|
| Milk | 2 | 2012 | 14 | 0.110 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 30 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2015 | 129 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2016 | 158 | 0.110 |
Why?
|
| Swine | 1 | 2013 | 79 | 0.110 |
Why?
|
| Models, Animal | 1 | 2013 | 114 | 0.110 |
Why?
|
| Clinical Chemistry Tests | 2 | 2006 | 5 | 0.110 |
Why?
|
| Guilt | 1 | 2013 | 5 | 0.110 |
Why?
|
| Organizational Culture | 1 | 2013 | 18 | 0.100 |
Why?
|
| Surveys and Questionnaires | 3 | 2015 | 1144 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2014 | 138 | 0.100 |
Why?
|
| Propensity Score | 1 | 2013 | 36 | 0.100 |
Why?
|
| Motivation | 1 | 2013 | 85 | 0.100 |
Why?
|
| Mammary Glands, Human | 1 | 2012 | 7 | 0.100 |
Why?
|
| Morphogenesis | 1 | 2012 | 8 | 0.100 |
Why?
|
| Microbiota | 1 | 2013 | 95 | 0.100 |
Why?
|
| Quadruplets | 1 | 1992 | 1 | 0.100 |
Why?
|
| Body Height | 1 | 1992 | 34 | 0.100 |
Why?
|
| Food Contamination | 1 | 2011 | 3 | 0.100 |
Why?
|
| Toxoplasma | 1 | 2011 | 7 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 125 | 0.090 |
Why?
|
| Reference Values | 1 | 2011 | 186 | 0.090 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2010 | 4 | 0.090 |
Why?
|
| Lactoferrin | 1 | 2010 | 9 | 0.090 |
Why?
|
| Cultured Milk Products | 1 | 2009 | 3 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3485 | 0.080 |
Why?
|
| Evidence-Based Medicine | 2 | 2020 | 161 | 0.080 |
Why?
|
| Models, Nursing | 2 | 2004 | 21 | 0.080 |
Why?
|
| Infant Food | 2 | 2004 | 2 | 0.080 |
Why?
|
| Personal Satisfaction | 1 | 2008 | 43 | 0.070 |
Why?
|
| Equipment Design | 2 | 2007 | 138 | 0.070 |
Why?
|
| Observer Variation | 6 | 2000 | 96 | 0.070 |
Why?
|
| Midwifery | 1 | 2007 | 1 | 0.070 |
Why?
|
| Nursing Diagnosis | 1 | 2007 | 2 | 0.070 |
Why?
|
| Kenya | 1 | 2007 | 11 | 0.070 |
Why?
|
| Models, Biological | 1 | 2009 | 322 | 0.070 |
Why?
|
| Data Collection | 2 | 2002 | 91 | 0.070 |
Why?
|
| Toxoplasmosis, Ocular | 1 | 2006 | 2 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2007 | 260 | 0.070 |
Why?
|
| Vision Disorders | 1 | 2006 | 20 | 0.070 |
Why?
|
| North America | 2 | 2018 | 41 | 0.060 |
Why?
|
| Risk Management | 1 | 2005 | 5 | 0.060 |
Why?
|
| Ethics, Research | 1 | 2005 | 3 | 0.060 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2005 | 1 | 0.060 |
Why?
|
| Toxoplasmosis | 1 | 2005 | 6 | 0.060 |
Why?
|
| Nursing Assessment | 1 | 2005 | 20 | 0.060 |
Why?
|
| Object Attachment | 1 | 2004 | 1 | 0.060 |
Why?
|
| Prenatal Diagnosis | 1 | 2005 | 14 | 0.060 |
Why?
|
| Nursing Methodology Research | 1 | 2004 | 31 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2005 | 57 | 0.060 |
Why?
|
| Logistic Models | 2 | 2016 | 395 | 0.060 |
Why?
|
| Clinical Protocols | 2 | 2014 | 57 | 0.060 |
Why?
|
| Health Planning Support | 1 | 2003 | 1 | 0.050 |
Why?
|
| Healthy People Programs | 1 | 2003 | 2 | 0.050 |
Why?
|
| Databases, Bibliographic | 1 | 2003 | 7 | 0.050 |
Why?
|
| Policy Making | 1 | 2003 | 12 | 0.050 |
Why?
|
| Politics | 1 | 2003 | 11 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2003 | 25 | 0.050 |
Why?
|
| Conflict of Interest | 1 | 2003 | 13 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2003 | 220 | 0.050 |
Why?
|
| Holistic Nursing | 1 | 2002 | 4 | 0.050 |
Why?
|
| Cross Infection | 1 | 2005 | 301 | 0.050 |
Why?
|
| Research Design | 1 | 2002 | 185 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 292 | 0.040 |
Why?
|
| Silicones | 1 | 2000 | 11 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 204 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 3 | 1994 | 32 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2020 | 75 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2006 | 985 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 112 | 0.040 |
Why?
|
| Administration, Oral | 2 | 2010 | 108 | 0.040 |
Why?
|
| Single-Blind Method | 2 | 1996 | 102 | 0.040 |
Why?
|
| Oceania | 1 | 2018 | 3 | 0.040 |
Why?
|
| Asia | 1 | 2018 | 10 | 0.040 |
Why?
|
| Africa | 1 | 2018 | 10 | 0.040 |
Why?
|
| Europe | 1 | 2018 | 58 | 0.040 |
Why?
|
| Internationality | 1 | 2018 | 21 | 0.040 |
Why?
|
| North Carolina | 1 | 2018 | 12 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 347 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 587 | 0.040 |
Why?
|
| Food, Fortified | 1 | 2018 | 9 | 0.040 |
Why?
|
| F2-Isoprostanes | 1 | 2018 | 7 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2018 | 43 | 0.040 |
Why?
|
| Income | 1 | 2018 | 80 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 94 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 189 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2017 | 38 | 0.030 |
Why?
|
| Health | 1 | 1996 | 10 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2016 | 43 | 0.030 |
Why?
|
| Phylogeny | 1 | 2016 | 51 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 44 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2016 | 58 | 0.030 |
Why?
|
| Feces | 1 | 2016 | 103 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2015 | 9 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2015 | 10 | 0.030 |
Why?
|
| Biological Availability | 1 | 2015 | 17 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 181 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2015 | 113 | 0.030 |
Why?
|
| Cell Line | 1 | 2015 | 273 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 79 | 0.030 |
Why?
|
| Transportation of Patients | 1 | 1994 | 3 | 0.030 |
Why?
|
| Nurse Clinicians | 1 | 1994 | 9 | 0.030 |
Why?
|
| Research Personnel | 1 | 1994 | 19 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 1994 | 24 | 0.030 |
Why?
|
| Group Processes | 1 | 1994 | 14 | 0.030 |
Why?
|
| Consultants | 1 | 1993 | 1 | 0.030 |
Why?
|
| Workload | 1 | 1993 | 29 | 0.030 |
Why?
|
| Mammary Glands, Animal | 1 | 2012 | 1 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2012 | 43 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 8 | 0.020 |
Why?
|
| Cesarean Section | 1 | 1992 | 30 | 0.020 |
Why?
|
| Fetal Development | 1 | 2012 | 3 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 71 | 0.020 |
Why?
|
| Oocysts | 1 | 2011 | 2 | 0.020 |
Why?
|
| Antibodies, Protozoan | 1 | 2011 | 5 | 0.020 |
Why?
|
| Patient Care Team | 1 | 1993 | 119 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2012 | 32 | 0.020 |
Why?
|
| Immunoassay | 1 | 2011 | 38 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2011 | 29 | 0.020 |
Why?
|
| Mice | 1 | 2015 | 1395 | 0.020 |
Why?
|
| Bodily Secretions | 1 | 2010 | 1 | 0.020 |
Why?
|
| Weights and Measures | 1 | 1990 | 3 | 0.020 |
Why?
|
| Methods | 1 | 1990 | 12 | 0.020 |
Why?
|
| Cephalometry | 1 | 1989 | 5 | 0.020 |
Why?
|
| Trachea | 1 | 2010 | 46 | 0.020 |
Why?
|
| Equipment and Supplies | 1 | 1989 | 10 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 474 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 785 | 0.020 |
Why?
|
| Vision, Binocular | 1 | 2006 | 2 | 0.020 |
Why?
|
| Vision, Monocular | 1 | 2006 | 2 | 0.020 |
Why?
|
| Macula Lutea | 1 | 2006 | 3 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2006 | 11 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2006 | 16 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2006 | 41 | 0.020 |
Why?
|
| Pattern Recognition, Visual | 1 | 2006 | 18 | 0.020 |
Why?
|
| Language Tests | 1 | 2006 | 33 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2005 | 85 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2004 | 29 | 0.010 |
Why?
|
| Urban Population | 1 | 2004 | 153 | 0.010 |
Why?
|
| Electronics | 2 | 1995 | 9 | 0.010 |
Why?
|
| Safety | 1 | 2002 | 37 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2000 | 38 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2000 | 406 | 0.010 |
Why?
|
| Critical Illness | 1 | 1995 | 117 | 0.010 |
Why?
|
| Transducers, Pressure | 1 | 1992 | 4 | 0.010 |
Why?
|